U.S., March 26 -- ClinicalTrials.gov registry received information related to the study (NCT07493447) titled 'Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures' on Feb. 25.
Brief Summary: This pilot clinical study evaluates the safety and imaging performance of panitumumab-IRDye800 (pan800), a fluorescent, EGFR-targeted imaging agent - in patients undergoing neurosurgical resection of intracranial lesions.
Study Start Date: May 02
Study Type: INTERVENTIONAL
Condition:
Meningioma
Glioblastoma
Acoustic Neuroma
Brain Cancer
Pituitary Adenoma
Intervention:
DRUG: Panitumumab-IRDye800
Subjects receive a single infusion of panitumumab-IRDye800 (pan800) and...